Conference Description:
This webinar addresses evolving regulatory requirements for particulates and the techniques suitable for testing and characterizing sub-visible particulates in therapeutic formulations.
Areas Covered in the Seminar:
Current Regulatory requirements for testing particulates in protein Therapeutics.
The limitations of the USP methods for testing Particulates.
What are the methods available for analysis of subvisible particles in protein therapeutics?
Comparison of size ranges, sensitivity limits and capabilities of the various methods.
Equipment available for performing these tests.
Advantages and disadvantages of the methods.
Who Will Benefit:
This course will benefit all individuals involved in Formulating or Testing Protein Therapeutics
QC Supervisors and Management
QC personnel
QA personnel
QA Management
Documentation management specialists
Regulatory affairs personnel
R&D Lab personnel
R&D Lab Supervisors